Interferon-a (IFN-a) is an immunomodulator whose antiviral and antiproliferative effects are well-established (Baron et al., 1987) . Successful entrapment of IFN-a in liposomes (Anderson et al., 1981; Eppstein and Stewart, 1981, 1982) has encouraged attempts to use the latter as a drug delivery system for the protein. For example, it has been shown that when IFN-(Y is encapsulated in liposomes and injected intramuscularly in mice, interferon is retained at the site of injection for much longer times than free IFN-(U is (Eppstein and Stewart, 1982) . The dependence of the ability of liposomes to entrap interferon, on the lipid composition, prompts the need to study the protein's interactions with lipid assemblies. One method which has been used to study polypeptide-lipid interactions is the monolayer technique in which a lipid is spread on the surface of a buffer, the polypeptide is injected into the subphase, and the extent of the resulting interaction is determined by measuring the change in surface pressure (Kimelberg and Papahadjopoulos, 1971; Schwinke et al., 1983) . Such techniques provide insight into protein interactions with artificial (Kimelberg and Papahadjopoulos, 1971 ) and natural (Bougis et al., 1981) (Pestka, 1983) .
The monolayer penetration studies were performed by a modification of a procedure reported by Schwinke et al. (1983) . The following lipid mixtures were used (mole ratios are given in parentheses):
DMPC : PC (2 : 1) and DMPC : SA (2 : 1). The experiments were performed at 25 + 1°C = 2" C above the phase transition of DMPC (Janiak et al., 1976) . A Rosano Surface Tensiometer (Laboratory Products, Boston, MA) having a sensitivity of 0.05 dyne/cm, equipped with a sandblasted platinum Wilhelmy plate was used to measure surface tension. The subphase consisted of 90.0 ml of 0.05 M N-2_hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES) at pH 7.0. Sodium chloride was added to adjust the ionic strength to 0.2. The solution was contained in a circular polytetrafluoroethylene dish 7.63 cm in internal diameter.
A polytetrafluoroethylenecoated magnetic stirrer was used for mixing the subphase (= 80 rpm) without disturbing the surface. The entire apparatus was enclosed to reduce airborne contamination.
The pure lipid or lipid mixture was spread from a solution of n-hexane: ethanol (9 : 1, v/v) by means of an Agla micrometer syringe (Wellcome Reagents, Beckenham, U.K.) in amounts sufficient to produce the desired initial surface pressure. The addition of the spreading solvent alone to a clean buffer surface produced no measurable change in surface tension.
A stationary needle with a removable glass syringe was used to deliver 460 pg IFN-cx in 0.2 ml of solution beneath the surface into the subphase so that the final concentration of IFN-a was 5.1 pg/ml. An equal volume of the subphase was removed prior to the addition so as to keep the total volume constant.
Surface tension readings were taken every 5 min until no further changes could be observed ( < 0.05 dyne/cm) for 30 min. In almost all cases, surface tension changes due to protein addition were virtually complete within 30 min.
Surface pressure, 7~, was calculated as the difference in surface tension in the absence of the lipid film and that of the film-covered surface. The change in surface pressure, Arr, was calculated as the difference in surface pressure of the lipid film upon injection of protein into the subphase and that of the film in the absence of protein, i.e. at its initial surface pressure.
When increasing amounts of IFN-(U were introduced into the subphase in the absence of a lipid monolayer, the measured surface pressures approached an asymptotic value at high IFN-a! concentrations.
Extrapolation to infinite IFN-a concentration of a plot of surface pressure vs reciprocal concentration gave a limiting pressure of 22.6 dyne/cm (Fig. 1) . For the lipid monolayer penetration experiments, a working IFN-(w con- centration of 5.1 pg/ml was chosen because this concentration yielded a surface pressure of about 15 dyne/cm, equivalent to about 70% of the limiting pressure. Fig. 2 shows the change in surface pressure caused by IFN-a as a function of initial surface pressure for 3 different lipid monolayers.
In each case, as the initial surface pressure increases, AT decreases until it becomes zero at approximately 20 dyne/cm. This value is slightly less than the limiting pressure of the protein film. As seen in Fig. 2 , this trend appears, under the conditions of the experiment, to be independent of lipid charge suggesting that IFN-(U is unable to penetrate the lipid monolayers used when these are spread at pressures greater than its own limiting pressure.
An implication of these observations is that, although IFN-a is quite surface-active by itself (mellitin, considered one of the most surface-active biological compounds (Bougis et al., 1981) has a limiting pressure of 24.5 dyne/cm (Sessa et al., 1969) ) it seems to lack the features necessary for penetration into lipid films at surface pressures above its own limiting pressure. It has been known for some time that proteins and polypeptides which can penetrate lipid monolayers well above their limiting pressures, i.e. at pressures of about 30 dyne/cm or more, can cause cell lysis (Bougis et al., 1981) increased permeability to ions (Kimelberg and Papahadjopoulos, 1971; Sessa et al., 1969) and may be found associated with biological membranes (Shiffer et al., 1988) . Conversely, those proteins which are unable to penetrate lipid monolayers above their limiting pressures do not exhibit any of these properties.
IFN-a appears to be one such protein. It should be pointed out though, that the ability of a protein to interact with a monolayer is dependent on a number of parameters, the most important being the charge on the lipid and the subphase pH and ionic strength (Kimelberg and Papahadjopoulos, 1971; Khaiat and Miller, 1969) . Therefore, extrapolations of monolayer results to biological effects should be made with caution.
It has been proposed and demonstrated in several cases (Segrest and Feldmann, 1974) This pressure is at least twice the pressure at which the DMPC monolayer "squeezes out" IFN-(Y. Thus, there is good reason to expect that IFN-(w, when entrapped in DMPC liposomes (and probably in other lipid vesicles) will be confined to the aqueous compartments between the lipid bilayers. This, of course, does not preclude interferon's association with the lipid bilayer, but simply means that the polypeptide is not in an area-determining position. It has been previously reported (Eppstein and Stewart, 1981, 1982 ) that human IFN-a is entrapped in lipo-somes but it was unclear whether the polypeptide was in the aqueous compartments only or intercalated within the lipid bilayers as well. The evidence presented here suggests strongly that very little, if any, interferon would penetrate into the bilayer.
